Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory … EE Ozkan Molecular and cellular endocrinology 344 (1-2), 1-24, 2011 | 79 | 2011 |
A case of renal synovial sarcoma treated with adjuvant ifosfamide and doxorubicin EE Ozkan, H Mertsoylu, HI Ozardali Internal Medicine 50 (15), 1575-1580, 2011 | 35 | 2011 |
A case report of benign schwannoma of the liver EE Ozkan, ME Guldur, A Uzunkoy Internal Medicine 49 (15), 1533-1536, 2010 | 24 | 2010 |
Radiotherapy for gastrointestinal stromal tumors EE Ozkan Chinese medical journal 131 (2), 235-240, 2018 | 17 | 2018 |
Predictive value of immune‐inflammation indices in metabolic response and outcome after curative radiotherapy in patients with non‐small cell lung cancer EE Ozkan, ZA Kaymak Cerkesli, M Erdogan The Clinical Respiratory Journal 14 (9), 849-856, 2020 | 15 | 2020 |
The effect of ionizing radiation on properties of fluoride-releasing restorative materials M Ugurlu, EE Ozkan, A Ozseven Brazilian Oral Research 34, e005, 2020 | 15 | 2020 |
The influence of systemic inflammation response index on survival outcomes of limited‐stage small‐cell lung cancer patients treated with concurrent Chemoradiotherapy A Kucuk, EE Ozkan, S Eskici Oztep, H Mertsoylu, B Pehlivan, U Selek, ... Journal of Oncology 2020 (1), 8832145, 2020 | 12 | 2020 |
Evaluating the predictive value of quantec rectum tolerance dose suggestions on acute rectal toxicity in prostate carcinoma patients treated with IMRT EE Ozkan, A Ozseven, ZAK Cerkesli Reports of Practical Oncology & Radiotherapy 25 (1), 50-54, 2020 | 7 | 2020 |
The esophageal dose–volume parameters for predicting Grade I–II acute esophagitis correlated with weight loss and serum albumin decrease in lung cancer radiotherapy ZAK Cerkesli, EE Ozkan, A Ozseven Journal of Cancer Research and Therapeutics 17 (1), 94-98, 2021 | 6 | 2021 |
Dosimetric evaluation of field-in-field and slidingwindow IMRT in endometrium cancer patients with a new approach for the conformity index A Özseven, EE Özkan International Journal of Radiation Research 18 (4), 853-862, 2020 | 6 | 2020 |
The role of Ga-68 PSMA PET/CT scan on differentiating of oligometastatic and high risk prostate cancer M Erdoğan, EE Özkan, SA Öztürk, M Yıldız, SS Şengül Molecular Imaging and Radionuclide Therapy 29 (3), 98, 2020 | 6 | 2020 |
A high pan-immune-inflammation value before chemoradiotherapy indicates poor outcomes in patients with small-cell lung cancer A Kucuk, E Topkan, EE Ozkan, D Ozturk, B Pehlivan, U Selek International Journal of Immunopathology and Pharmacology 37, 03946320231187759, 2023 | 4 | 2023 |
Mismatch repair mutations: Biomarker for immunotherapy in colorectal cancers S Shenoy Indian Journal of Cancer 60 (3), 415-417, 2023 | 3 | 2023 |
The Association of Death Anxiety, Loneliness, and Hopelessness with Clinical Features and Qualityof Life in Palliative Radiotherapy Patients. ZA KAYMAK, G ÖZDAMAR ÜNAL, EE ÖZKAN Turkish Journal of Oncology/Türk Onkoloji Dergisi 37 (3), 2022 | 3 | 2022 |
Impact of diabetes on gastrointestinal and urinary toxicity after radiotherapy for gynecologic malignancy EE Özkan, E Erdemoğlu, J Raoufi Turkish Journal of Obstetrics and Gynecology 16 (4), 260, 2019 | 3 | 2019 |
Evre IB-III Serviks Kanserinde Definitif ve Adjuvan Radyoterapi Sonuçlarının Karşılaştırmalı Değerlendirilmesi ZA KAYMAK, EE ÖZKAN Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 7 (2), 117-122, 2020 | 2 | 2020 |
Incidence of suspicious axillary lymph node involvement in fluorine-18 fluoro-D-glucose positron emission tomography/computed tomography in gynecologic cancers J Raoufi, SC İşcan, C Hanedan, EE Özkan, SS Çerçi, E Erdemoğlu, ... Turkish Journal of Obstetrics and Gynecology 15 (2), 99, 2018 | 2 | 2018 |
Radiotherapy for benign diseases in Turkey: a patterns of care survey of the Turkish Society for Radiation Oncology (TROD 05-002) HC Yıldırım, FÖ Dinçbaş, V Demircan, M Beyzadeoğlu, E Tekçe, G Yazıcı, ... Strahlentherapie und Onkologie 200 (2), 143-150, 2024 | 1 | 2024 |
High pre-chemoradiotherapy pan-immune-inflammation value levels predict worse outcomes in patients with stage IIIB/C non-small-cell lung cancer E Topkan, A Kucuk, EE Ozkan, D Ozturk, AA Besen, H Mertsoylu, ... Discover Oncology 14 (1), 230, 2023 | 1 | 2023 |
The prognostic value of decrease in prognostic nutritional index in stage III non-small cell lung cancer patients during curative thoracic radiotherapy ZA Kaymak, EE Ozkan Indian Journal of Cancer 60 (1), 18-23, 2023 | 1 | 2023 |